Cointime

  • 快讯
  • 头条
  • 行情
  • 专栏
  • 活动
  • 比特币 ¥656,765.74 +2.79%
  • 以太坊 ¥22,464.21 +3.19%
  • 币安币 ¥6,472.28 +1.67%
  • Optimism ¥2.30 +3.44%
  • Arbitrum ¥1.51 +2.13%
  • Solana ¥987.37 +3.98%
  • Polygon ¥1.56 +2.77%
  • Cosmos ¥15.95 +1.63%
  • Avalanche ¥98.06 +2.50%
  • 比特币 ¥656,765.74 +2.79%
  • 以太坊 ¥22,464.21 +3.19%
  • 币安币 ¥6,472.28 +1.67%
  • Optimism ¥2.30 +3.44%
  • Arbitrum ¥1.51 +2.13%
  • Solana ¥987.37 +3.98%
  • Polygon ¥1.56 +2.77%
  • Cosmos ¥15.95 +1.63%
  • Avalanche ¥98.06 +2.50%
Home / Kala Pharmaceuticals / investors

Kala Pharmaceuticals

company

Investors

Number of Lead Investors
Number of Investors
5
15
Kala Pharmaceuticals is funded by 15 investors. Oxford Finance LLC and Athyrium Capital Management LP are the most recent investors.
Investor Name Lead Investor Funding Round
Oxford Finance LLC Yes Post-IPO Debt
Athyrium Capital Management LP Yes Post-IPO Equity
Longitude Capital Yes Series C
Ysios Capital Yes Series B
CAM Capital - Series C
Lux Capital - Series C
OrbiMed - Series C
Polaris Partners - Series C
RA Capital Management - Series C
Vivo Capital - Series C
Wellington Management - Series C
AbbVie Biotech Ventures - Series B
Crown Venture Fund - Series B
Third Rock Ventures - Series B
Lighthouse Capital Partners - Private Equity(PE)

Contact

Waltham,Massachusetts,United States
1(781) 996-5252
Cointime
头条
  • 即时新闻
  • 全球政策
  • 比特币
  • 以太坊
  • 狗狗币
  • 区块链
  • 元宇宙
  • 区块链游戏
  • Web3
  • DeFi
  • NFT
热点
  • 项目报道
  • 行业洞见
  • 新闻
  • 教程
  • 政策解读
  • 专题
  • 专栏
  • 行情
  • 活动
  • 标签
RSS
  • 即时新闻
  • 头条
公司
  • 关于我们
  • 广告合作
  • 免责声明
  • © 2023 Cointime. 版权所有
  • 隐私政策
  • 服务条款